Publications by Dr Susan Tudhope - ePrints

Browsing publications by Dr Susan Tudhope.

Newcastle Authors	Title	Year
Dr Evan Mulligan Dr Susan Tudhope Dr Jill Hunter Sarah Elliott Dr Jonathan Wallis et al.	Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling	2023
Dr Catherine Salvini Benoit Darlot Jack Davison Dr Mathew Martin Dr Susan Tudhope et al.	Fragment expansion with NUDELs – poised DNA-encoded libraries	2023
Islam Al-Khawaldeh Dr Christine Basmadjian Dr Cinzia Bordoni Dr Suzannah Harnor Amy Heptinstall et al.	An alkynylpyrimidine-based covalent inhibitor that targets a unique cysteine in NF-κB-inducing kinase (NIK)	2021
Dr Timothy Barrow Dr Sirintra Nakjang Kateryna Bilotkach Dr Laura Woodhouse Gesa Junge et al.	Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia	2021
Dr Catherine Willoughby Huw Thomas Dr Elaine Willmore Suzanne Kyle Dr Anita Wittner et al.	Selective DNA-PKcs Inhibition Extends the Therapeutic Index of Localized Radiotherapy and Chemotherapy	2019
Christopher Coxon Dr Suzannah Harnor Dr Mathew Martin Dr Benoit Carbain Emeritus Professor Bernard Golding et al.	Cyclin-Dependent Kinase (CDK) Inhibitors; Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines	2017
Dr Ziad Al-Oanzi Sofia Fountana Tabassum Moonira Dr Susan Tudhope John Petrie et al.	Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes	2017
Dr Timothy Barrow Dr Laura Woodhouse Gesa Junge Dr Susan Tudhope Dr Jonathan Wallis et al.	The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy	2016
Dr Elaine Willmore Dr Aaron Ions Gardner Dr Susan Tudhope Belinda Murtani Jessica Caffry et al.	Novel small molecule IKK alpha inhibitors inhibit non- canonical NF-kappa B signaling and survival of primary CLL cells	2015
Dr Ashleigh Herriott Dr Susan Tudhope Gesa Junge Natalie Rodrigues Dr Miranda Patterson et al.	PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia	2015
Dr Helen Marr Dr Luke Gaughan Dr Susan Tudhope Professor James Allan	Regulation of CD38 in IRF4 in Chronic Lymphocytic Leukaemia	2015
Dr Susan Tudhope Dr Yan Zhao Dr Anita Wittner Annalisa Bertoli Santosh Adhikari et al.	Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels	2014
Dr Alessio Iannetti Dr Adeline Ledoux Dr Susan Tudhope Helene Sellier Adam Moore et al.	Regulation of p53 and Rb Links the Alternative NF-kappaB Pathway to EZH2 Expression and Cell Senescence	2014
Annalisa Bertoli Santosh Adhikari Dr Suzannah Harnor Dr Yan Zhao Professor John Lunec et al.	Validation studies with small-molecule modulators of the MDM2/MDMX-p53 binding interaction	2014
Dr John Petrie Dr Ziad Al-Oanzi Dr Catherine Arden Dr Susan Tudhope Professor Jelena Mann et al.	Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter	2013
Dr Susan Tudhope Dr Fiona Malcomson Dr Catherine Arden Dr Laura Hampson Professor Loranne Agius et al.	A Novel Mechanism for Regulating Hepatic Glycogen Synthesis Involving Serotonin and Cyclin-Dependent Kinase-5	2012
Dr Catherine Arden Dr Susan Tudhope Dr Ziad Al-Oanzi Kirsty Cullen Professor Loranne Agius et al.	Fructose 2,6-bisphosphate is essential for glucose-regulated genetranscription of glucose-6-phosphatase and other ChREBP target genes inhepatocytes	2012
Dr Susan Tudhope Dr Evan Mulligan Dr Jill Hunter Dr Helen Marr Professor barbara Durkacz et al.	P B S-1086, a "Pan-Rel" Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells	2012
Dr Ziad Al-Oanzi Dr John Petrie Dr Susan Tudhope Dr Catherine Arden Professor Loranne Agius et al.	The insulin-independent glucose-induction of the hepatic gluconeogenic enzyme glucose 6-phosphatase involves distinct metabolic pathways and transcription factors	2012
Dr Catherine Arden Dr Susan Tudhope Dr Ziad Al-Oanzi Professor Loranne Agius	Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis	2011
Professor Fai Ng Dr Susan Tudhope Dr Alexei von Delwig Dr Desa Lilic	Invariant natural killer T (iNKT) cell deficiency in chronic mucocutaneous candidiasis - A consequence or a cause?	2011
Dr Susan Tudhope Dr Alexei von Delwig Dr Jane Falconer Dr Arthur Pratt Professor John Isaacs et al.	Profound invariant natural killer T-cell deficiency in inflammatory arthritis	2010
Dr Alexei von Delwig Dr Arthur Pratt Dr Susan Tudhope Professor John Isaacs Professor Fai Ng et al.	Invariant natural killer T (iNKT) cells in early rheumatoid arthritis (RA)	2008
Dr Alexei von Delwig Dr Susan Tudhope Dr Arthur Pratt Professor John Isaacs Dr Desa Lilic et al.	The role of invariant natural killer T (iNKT) cells in rheumatoid arthritis	2008